🇺🇸 FDA
Patent

US 7626014

Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety

granted A61PA61P11/04A61P11/06

Quick answer

US patent 7626014 (Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
64
CPC classes
A61P, A61P11/04, A61P11/06, A61P17/00, A61P19/02